Pleuroparenchymal fibroelastosis in systemic sclerosis-associated interstitial lung disease

Turk J Med Sci. 2022 Feb;52(1):83-88. doi: 10.3906/sag-2107-13. Epub 2022 Feb 22.

Abstract

Background: To explore the frequency and clinical associations of radiologic pleuroparenchymal fibroelastosis (PPFE) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD).

Methods: In this single-center retrospective study, high resolution computed tomography (HRCT) images of 105 patients with SSc-ILD were examined for the presence of PPFE. Demographic, clinical, laboratory, and pulmonary function test (PFT) data of patients with and without PPFE were compared.

Results: PPFE was detected in 19 (18.1%) patients ('definite PPFE' in 13 and 'consistent with PPFE' in 6 patients). Patients with PPFE had higher age and longer disease duration than PPFE (-) patients (p < 0.05 for both). Radiologic usual interstitial pneumoniae (UIP) pattern was more frequent (26.3% vs. 4.7%, p = 0.01) and median force vital capacity (FVC) was lower in patients with PPFE (64% vs. 82%, p = 0.005). Spontaneous pneumothorax developed in one patient with PPFE. More deaths occured in PPFE (+) group during follow-up (31% vs. 11%, p = 0.04).

Keywords: interstitial lung disease; pleuroparenchymal fibroelastosis; Systemic sclerosis.

MeSH terms

  • Humans
  • Idiopathic Pulmonary Fibrosis*
  • Lung / diagnostic imaging
  • Lung Diseases, Interstitial* / complications
  • Lung Diseases, Interstitial* / diagnostic imaging
  • Respiratory Function Tests
  • Retrospective Studies
  • Scleroderma, Systemic* / complications